Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Hormone-Sensitive Breast Cancer|Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Bevacizumab
Sponsor: Yale University
Collaborators: Novartis|Genentech, Inc.